Rentokil

RTO

Market cap $17.3B

Rentokil Initial plc (RTO) Q1 2026 Sales/Trading Call Transcript

Rentokil Initial PLC (LSE:RTO) reported steady first-quarter growth, supported by pricing and improving demand in North America. The group said revenue rose 4.3% to $1.68 billion in the three months to March, with organic growth of 3.4%.

European stocks are expected to open in mixed territory as investors assess a confused picture of where the Iran war and peace talks are headed.

UBS has shared the key investor debates following its recent upgrade of Rentokil Initial PLC (LSE:RTO) to 'buy', with a 12-month price target of 540p, implying upside of around 11% from the current share price of 488p. The Swiss bank upgraded the pest control and hygiene services group on the basis that a reshaping of its North American pest control strategy could inflect volumes over the next 12 months, supporting what UBS described as the re-emergence of a valuable long-term compounder.

Annual Report and Annual General Meeting CRAWLEY, UK / ACCESS Newswire / March 25, 2026 / In compliance with UK Listing Rule 6.4.1, the Company announces that the following documents, in unedited full text, have today been filed with the Financial Conduct Authority and are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism: Annual Report and Financial Statements for the year ended 31 December 2025 (the Annual Report 2025); Notice of 2026 Annual General Meeting (AGM); and Proxy Form for the 2026 AGM. The documents will be posted today, and the Annual Report 2025 and the Notice of 2026 AGM have been published on the Company's website at rentokil-initial.com/investors.

Rentokil Initial PLC (LSE:RTO), the FTSE 100 pest control and hygiene services group, received a significant vote of confidence on Thursday as UBS upgraded the stock from neutral to buy. The Swiss bank also lifted its price target from 430p to 540p, arguing that three years of self-inflicted market share losses in North America are finally coming to an end.

Rentokil Initial plc (RTO) shows stabilization in 2025, with North America organic growth improving and streamlining efforts beginning to yield results. RTO's recurring significant earnings adjustments and complex reporting continue to obscure true underlying performance, justifying a valuation discount. Leverage remains elevated at 7.5x free cash flow, and although free cash flow covers the dividend, the balance sheet is not robust.

Rentokil (RTO) offers a more attractive valuation and diversified growth profile than peer Rollins, trading at a significant discount despite similar growth drivers. RTO reported FY'25 revenues of $6.91B (+3.8% YoY), with organic growth, margin expansion, and strong free cash flow supporting deleveraging and investment-grade credit ratings. Industry tailwinds, operational efficiencies, and a robust M&A pipeline underpin expectations for mid-to-high single-digit EPS growth and margin improvement toward 20%+ by 2027.

Rentokil Initial plc (RTO) Q4 2025 Earnings Call Transcript

Shares in Rentokil Initial PLC jumped 9.2% to 464.6p on Thursday as the pest control giant reported full-year results that met or beat market expectations, helped by improving momentum in North America. Revenue from continuing operations rose 4.4% to $6.9 billion and adjusted operating profit climbed 5.4% to $1.1 billion, both in line with the $6.9 billion City analyst consensus.